carbon monoxide has been researched along with paclitaxel in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dafni, U; Dimopoulos, MA; Dimopoulou, I; Galani, H; Roussos, C; Samakovii, A | 1 |
| Elliot, DJ; Lewis, BC; Miners, JO; Polasek, TM | 1 |
| Anthony, S; Chen, WC; Cooper, BW; Hanks, SH; Kim, E; Kim, J; Leeming, R; Lyons, JA; Overmoyer, B; Shenk, R; Silverman, P | 1 |
| Doyle, SL; Elliott, JA; Foley, G; Guinan, EM; King, S; Murphy, CF; O'Byrne, L; Ravi, N; Reynolds, JV | 1 |
| Kawahara, B; Mascharak, PK; Sen, S | 1 |
| Faull, KF; Janzen, C; Kawahara, B; Mascharak, PK | 1 |
1 review(s) available for carbon monoxide and paclitaxel
| Article | Year |
|---|---|
Reaction of carbon monoxide with cystathionine β-synthase: implications on drug efficacies in cancer chemotherapy.
Topics: Antineoplastic Agents; Carbon Monoxide; Cystathionine beta-Synthase; Doxorubicin; Drug Resistance, Neoplasm; Humans; Neoplasms; Paclitaxel; Reactive Oxygen Species | 2020 |
2 trial(s) available for carbon monoxide and paclitaxel
| Article | Year |
|---|---|
A phase II study of radiotherapy and concurrent paclitaxel chemotherapy in breast-conserving treatment for node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carbon Monoxide; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Humans; Lymphatic Irradiation; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Paclitaxel; Pulmonary Diffusing Capacity; Radiodermatitis | 2012 |
Effect of neoadjuvant chemoradiation on preoperative pulmonary physiology, postoperative respiratory complications and quality of life in patients with oesophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Carboplatin; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Postoperative Complications; Preoperative Care; Quality of Life; Respiration Disorders; Vital Capacity | 2019 |
3 other study(ies) available for carbon monoxide and paclitaxel
| Article | Year |
|---|---|
A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arteries; Carbon Monoxide; Carboplatin; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Lung; Lung Diseases; Male; Middle Aged; Ovarian Neoplasms; Paclitaxel; Prospective Studies; Pulmonary Diffusing Capacity; Respiratory Function Tests; Urinary Bladder Neoplasms | 2002 |
Mechanism-based inactivation of human cytochrome P4502C8 by drugs in vitro.
Topics: Algorithms; Antidepressive Agents, Tricyclic; Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; Carbon Monoxide; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Gene Expression Regulation; Humans; Hydroxylation; In Vitro Techniques; Microsomes, Liver; Monoamine Oxidase Inhibitors; Orexin Receptors; Paclitaxel; Plasmids; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Recombinant Proteins; Spectrophotometry, Ultraviolet; Sulfonamides; Testosterone; Torsemide; Ultrafiltration | 2004 |
Carbon Monoxide Inhibits Cytochrome P450 Enzymes CYP3A4/2C8 in Human Breast Cancer Cells, Increasing Sensitivity to Paclitaxel.
Topics: Antineoplastic Agents; Breast Neoplasms; Carbon Monoxide; Cell Line, Tumor; Cell Survival; Chloramphenicol; Coordination Complexes; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Screening Assays, Antitumor; Humans; Light; Manganese; Paclitaxel | 2021 |